Medicare drug subsidy ends, potentially raising costs for some seniors
The Trump administration has ended a Medicare drug subsidy program, a move that could lift out-of-pocket costs for certain beneficiaries and shift some expenses within Medicare. The impact will vary by individual drug needs and coverage, with broader implications for overall healthcare spending and policy.